InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Sullivan Louis W, 董事. Director active across 2 companies, notably Emergent BioSolutions Inc.. Cumulatively, 24 disclosures have been published. Activity tracked since 10 May 2021. The latest transaction was filed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sullivan Louis W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
650 股0Common StockSEC:0001193522-26-000001:0
3,230 股@ US$183.988.6% 占其流量Common StockSEC:0001193522-25-000004:0
590 股0Common StockSEC:0001562180-25-005524:0
34,403 股0Common StockSEC:0001367644-25-000103:0
15,000 股@ US$175.4340.8% 占其流量Common StockSEC:0001562180-24-008520:0
17,430 股0Common StockSEC:0001367644-24-000079:0
5,160 股@ US$119.769.4% 占其流量Common StockSEC:0001415889-24-012328:0
880 股0Common StockSEC:0001415889-23-010952:0
33,847 股0Common StockSEC:0001367644-23-000107:0
700 股@ US$132.301.4% 占其流量Common StockSEC:0001415889-23-003824:0
700 股@ US$132.301.4% 占其流量Common StockSEC:0001415889-23-001809:0
700 股@ US$132.301.4% 占其流量Common StockSEC:0001415889-23-000105:0
700 股@ US$132.301.4% 占其流量Common StockSEC:0001415889-22-011882:0
700 股@ US$132.301.5% 占其流量Common StockSEC:0001415889-22-010999:0
710 股@ US$132.301.6% 占其流量Common StockSEC:0001415889-22-010072:0
4,910 股@ US$101.808.2% 占其流量Common StockSEC:0001415889-22-009375:0
1,080 股0Common StockSEC:0001415889-22-007628:0
3,230 股0Common StockSEC:0001415889-22-007602:0
8,446 股0Common StockSEC:0001367644-22-000089:0
6,310 股@ US$76.360.0019% mcap22.1% 占其流量Common StockSEC:0001415889-22-005696:0
1,680 股0Common StockSEC:0001127602-21-020758:0
5,027 股0Common StockSEC:0001367644-21-000097:0
15,000 股@ US$63.9013.4% 占其流量Common StockSEC:0001127602-21-016406:0
10,305 股@ US$18.64100.0% 占其流量Common StockSEC:0001367644-21-000075:0
24 条申报中的 24 条
About Sullivan Louis W
SULLIVAN LOUIS W is Director at UNITED THERAPEUTICS Corp and Emergent BioSolutions Inc. He has 24 filings in total, and the sampled recent filings cover the period from 2021-05-11 to 2026-07-13, with a modal transaction nature listed as option exercise.
